Quantum X Labs Inc. QXL
5.00
(0.17)
(3.29%)
as of 25 Sep
- Market cap
- $111.8M
- P/E
- 34.2×
Follow QXL
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (13.37%) | (106.34%) | (308.66%) | (253.47%) |
+8 more TTM periods Free account |
|
| (8.11%) | (59.95%) | (117.87%) | (92.30%) | ||
ROIC |
1.93% | (7.56%) | (21.18%) | 16.09% | |
Return on Tangible Assets |
602.61% | 1,243.07% | 818.90% | 503.80% | |
Average Days of Receivables |
171.96 | 177.91 | 73.28 | (32.22) | |
Free Cash Flow per Share |
(0.30) | (0.31) | (0.33) | (0.30) | |
Free Cash Flow |
(4.34) | (3.56) | (2.77) | (3.14) | |
Capital Expenditures |
(0.19) | — | — | — | |
Piotroski F-Score |
4.00 | 4.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(13.74%) | (13.80%) | (32.50%) | (26.35%) | |
Accounts Receivable Turnover |
1.58 | 1.62 | 3.60 | (4.05) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.96) | (0.01) | 0.00 | (0.02) | |
Research and Development Expense of Revenue |
18.09% | 0.00% | 4.40% | 4.12% | |
Selling, General and Administrative Expense of Revenue |
188.91% | 145.94% | 109.94% | (3.87%) | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 4.97% | (0.40%) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.99 | 0.22 | 0.14 | 0.14 | |
Depreciation/Fixed assets |
4.35 | 20.43 | 15.14 | 19.85 | |
Capex/Depreciation |
(0.22) | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.09 | 0.12 | 0.19 | (1.43) | |
Operating CF per Share |
(0.29) | (0.31) | (0.33) | (0.30) | |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.15 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(157.98%) | (1,164.54%) | (1,229.13%) | 146.40% |
Columns are period end dates